Eli Lilly (LLY) stock plunges as Phase 3 trial data for the company's oral weight loss drug orforglipron overshadow better ...

State-owned National Aluminium Company Ltd (NALCO), apart from Q1 FY26 results, announced a dividend for its shareholders.

Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. Eli Lilly also released long-awaited ...

Key Points Non-GAAP earnings per share were $0.10 in Q2 2025, beating consensus estimates. Adjusted revenue rose 14%, slightly missing non-GAAP expectations but still reflecting strong testing ...